2-Aminoacetophenone as a potential breath biomarker for Pseudomonas aeruginosa in the cystic fibrosis lung

BMC Pulmonary Medicine

Volumn 10, Issue , 2010, Pages

  Scott Thomas, Amy J ^a   Syhre, Mona ^b   Pattemore, Philip K ^a   Epton, Michael ^c   Laing, Richard ^c   Pearson, John ^a   Chambers, Stephen T ^c  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c CANTERBURY DISTRICT HEALTH BOARD   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINOACETOPHENONE; BIOLOGICAL MARKER; QUINAZOLINE DERIVATIVE; UNCLASSIFIED DRUG; 2-AMINOACETOPHENONE; ACETOPHENONE DERIVATIVE;

ADOLESCENT; ADULT; ARTICLE; ASPERGILLUS FUMIGATUS; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM CULTURE; BREATH ANALYSIS; BURKHOLDERIA MULTIVORANS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE MARKER; ESCHERICHIA COLI; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; LEGIONELLA PNEUMOPHILA; LUNG CYSTIC FIBROSIS; LUNG DISEASE; MALE; MASS FRAGMENTOGRAPHY; MORAXELLA CATARRHALIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS FLUORESCENS; PSEUDOMONAS INFECTION; SENSITIVITY AND SPECIFICITY; SOLID PHASE MICROEXTRACTION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; CHEMISTRY; CHILD; CYSTIC FIBROSIS; GROWTH, DEVELOPMENT AND AGING; LUNG; METHODOLOGY; MICROBIOLOGY; MIDDLE AGED; RESPIRATORY TRACT INFECTION;

ACETOPHENONES; ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BREATH TESTS; CHILD; CYSTIC FIBROSIS; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; LUNG; MALE; MIDDLE AGED; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY TRACT INFECTIONS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 78049356367     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-10-56     Document Type: Article

References (30)

1. Mann S. Uber den Geruchsstoff von Pseudomonas aeruginosa. Archiv fur Mikrobiologie 1966, 54:184-190.
2. Cox C, Parker J. Use of 2-aminoacetophenone production in identification of Pseudomonas aeruginosa. Journal of Clinical Microbiology 1979, 9(4):479-484. 273058, 110829.
3. Mann S. Chinazolinderivate bei Pseudomonaden. Archiv fur Mikrobiologie 1967, 56:324-329. 10.1007/BF00425207, 4970237.
4. Labows J, McGinley K, Webster G, Leyden J. Headspace analysis of volatile metabolites of Pseudomonas aeruginosa and related species by gas chromatography-mass spectrometry. Journal of Clinical Microbiology 1980, 12(4):521-526. 273628, 6775012.
5. Scotter J, Allardyce R, Langford V, Hill A, Murdoch D. The rapid evaluation of bacterial growth in blood cultures by selected ion flow tube-mass spectrometry (SIFT-MS) and comparison with the BacT/ALERT automated blood culture system. Journal of Microbiological Methods 2006, 65:628-631. 10.1016/j.mimet.2005.09.016, 16271408.
6. Treggiari M, Rosenfeld M, Retsch-Bogart G, Gibson R, Ramsey B. Approach to eradication of initial Pseudomonas aeruginosa infection in children with cystic fibrosis. Pediatric Pulmonology 2007, 42:751-756. 10.1002/ppul.20665, 17647287.
7. Reynolds H, Levine A, Wood R, Zierdt C, Dale D, Pennington J. Pseudomonas infections: persisting problems and current research to find new therapies. Annals of Internal Medicine 1975, 82:819-832.
8. Palmer K, Aye L, Whiteley M. Nutritional cues control Pseudomonas aeruginosa multicellular behaviour in cystic fibrosis sputum. Journal of Bacteriology 2007, 189(22):8079-2027. 10.1128/JB.01138-07, 2168676, 17873029.
9. Nixon G, Armstrong D, Carzino R, Carlin J, Olinsky A, Roberston C, Grimwood K. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. Journal of Pediatrics 2001, 138(5):699-704. 10.1067/mpd.2001.112897, 11343046.
10. Dakin C, Numa A, Wang H, Morton J, Vertzyas C, Henry R. Inflammation, infection and pulmonary function in infants and young children with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine 2002, 165(7):904-910.
11. Hilliard T, Sukhani S, Francis J, Madden N, Rosenthal M, Balfour-Lynn I, Bush A, Davies J. Bronchoscopy following diagnosis with cystic fibrosis. Archives of Disease in Childhood 2006, 92(10):898-899. 10.1136/adc.2006.105825, 2083238, 17088336.
12. Douglas T, Brennan S, Gar S, Berry L, Gangell C, Stick S, Clements B, Sly P. Acquisition and eradication of P. aeruginosa in young children with cystic fibrosis. European Respiratory Journal 2009, 33(2):305-311. 10.1183/09031936.00043108, 19010992.
13. Rosenfeld M, Emerson J, Accurso F, Armstrong D, Castile R, Grimwood K, Hiatt P, McCoy K, McNamara S, Ramsey B, et al. Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis. Pediatric Pulmonology 1999, 28:321-328. 10.1002/(SICI)1099-0496(199911)28:5<321::AID-PPUL3>3.0.CO;2-V, 10536062.
14. Ramsey B, Wentz K, Smith A, Richardson M, Williams-Warren J, Hedges D, Gibson R, Redding G, Lent K, Harris K. Predictive value of oropharyngeal cultures for identifying lower airway bacteria in cystic fibrosis patients. American Review of Respiratory Disease 1991, 144(2):331-337.
15. Forbes B, Sahm D, Weissfeld A. Diagnostic Microbiology. 2002, Missouri: Mosby, Eleventh.
16. Mahenthiralingam E, Bishof J, Byrne S, Radomski C, Davies J, Av-Gay Y, Vandamme P. DNA-based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. Journal of Clinical Microbiology 2000, 38(9):3165-3173. 87345, 10970351.
17. Atlas RM. Handbook of microbiological media. 2004, Kentucky: CRC Press, Third.
18. Ritz C, Streiburg J. Bioassay analysis using R.J. Statist. Software 2010, 12(5).
19. R: A language and environment for statistical computing. R Foundation for Statistical Computing 2010, Vienna, Austria, Team RDC.
20. Amann A, Smith D. Breath analysis for clinical diagnosis and therapeutic monitoring. 2005, Singapore: World Scientific Printers (S) Pte Ltd, First.
21. Habs H, Mann S. Die bildung von ortho-aminoacetophenon durch apyacyanogene stamme von Pseudomonas aeruginosa. Zentralbl Bakteriol Parasitenkd Infektionskr hyg abt 1967, 203:473-477.
22. Gottschalk P, CDunn J. The five-parameter logistic: a characterization and comparison with the four-paramter logistic. Analytical biochemistry 2005, 343:54-65. 10.1016/j.ab.2005.04.035, 15953581.
23. Syhre M, Scotter J, Chambers S. Investigation into the production of 2-Pentylfuran by Aspergillus fumigatus and other respiratory pathogens in vitro and human breath samples. Medical Mycology 2007, 46:209-215.
24. Syhre M, Chambers S. The scent of Mycobacterium tuberculosis. Turberculosis 2008, 88(4):317-323.
25. Syhre M, Manning L, Harino P, Chambers S. The scent of Mycobacterium tuberculosis - part II. Tuberculosis 2009, 89:263-266. 10.1016/j.tube.2009.04.003, 19481976.
26. Chambers S, Syhre M, Murdoch D, McCartin F, Epton M. Detection of 2-pentylfuran in the breath of patients with Aspergillus fumigatus. Medical Mycology 2009, 47(5):468-476. 10.1080/13693780802475212, 19301177.
27. Schmarr H, Gan S, Sang W, Potouridis T. Analysis of 2-aminoacetophenone in wine using a stable isotope dilution assay and multidimensional gas chromatography-mass spectrometry. Journal of Chromatography A 2007, 1150:78-84. 10.1016/j.chroma.2006.09.001, 17014858.
28. Fan W, Tsai I, Qian M. Analysis of 2-aminoacetophenone by direct-immersion solid-phase microextraction and gas chromatography-mass spectrometry and its sensory impact in Chardonnay and Pinot gris wines. Food Chemistry 2007, 105:1144-1150.
29. Karagul-Yuceer Y, Cadwallader K, Drake M. Volatile flavor components of stored nonfat dry milk. Journal of Agricultural Food and Chemistry 2002, 50:305-312.
30. O'Hara M, O'Hehir S, Green S, Mayhew C. Development of a protocol to measure volatile organic compounds in human breath: a comparison of rebreathing and on-line single exhalations using proton transfer reaction mass spectrometry. Physiological Measurement 2008, 29:309-330. 10.1088/0967-3334/29/3/003, 18367807.